Clinical Trial Update: Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating concurrent chemoradiotherapy combined with recombinant human endostatin for locally advanced non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Non-small Cell Lung Cancer | Phase 4 | Status: UNKNOWN